Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.
about
Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chancesCurrent and future implications of basic and translational research on amyloid-β peptide production and removal pathwaysOlder Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention.An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's diseaseVascular and Metabolic Factors in Alzheimer's Disease and Related Dementias: IntroductionPathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease.Is Vasomotion in Cerebral Arteries Impaired in Alzheimer's Disease?New Insights into Epigenetic and Pharmacological Regulation of Amyloid-Degrading Enzymes.Hyperhomocysteinemia impairs regional blood flow: involvements of endothelial and neuronal nitric oxide.Sex Hormone Decline and Amyloid β Synthesis, Transport and Clearance in the Brain.Renin-angiotensin system gene expression and neurodegenerative diseases.Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure.Editorial on, "Amyloid-beta clearance in Alzheimer's disease".The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease.BOLD neurovascular coupling does not change significantly with normal aging.Differing associations between Aβ accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease.Cerebral Hypoperfusion and the Energy Deficit in Alzheimer's Disease.
P2860
Q27027707-7C2177EA-833E-4331-9839-E8C7A339644EQ28081678-DB72AB75-4810-40B1-932F-64D21838E2DEQ33822159-50E22E5D-4AD8-40B3-AAA9-A3DEE5C66FA5Q35907609-1C29FA82-7689-405F-B19B-0FDB21542825Q36840056-CD6061E5-622A-41A0-886A-6EFAAE3E3C17Q37169574-9FC09A9E-8213-43A6-BA52-9DD6584BF242Q38365567-6B0D31C1-ED8B-48BB-A2AB-1E94360F17DDQ38834930-5527A6A9-04D2-4532-A0C2-2D8D5777998FQ38896912-6445AAFF-A68E-431D-B73D-8BD146598A72Q38955319-D875D462-F944-48CB-95F6-3F96F4119CDBQ39404819-DE14193B-7EF5-4F61-A6DC-67C6D3D5140FQ40000430-81FEC4EC-2F0B-44E5-B70B-9A5599A1B769Q43015317-593E5E7F-5568-4E95-A9B1-0417536ABDF0Q47257826-762FF8D6-0EF1-49D2-8B60-C597DFDD4D30Q48263259-18D5586C-8D99-4C1E-A83D-F089B620CE47Q48328265-91EEE838-59D1-4FBF-A687-A9CFBD9FEE5CQ48663991-25ED1C72-D8C9-40E6-A6AD-2382D9A4EFB0
P2860
Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.
@en
type
label
Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.
@en
prefLabel
Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.
@en
P2093
P2860
P356
P1476
Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.
@en
P2093
Emma Ashby
J Scott Miners
Jennifer C Palmer
Laura E Palmer
P2860
P356
10.3389/FNAGI.2014.00238
P577
2014-09-11T00:00:00Z